10.12.2012 Views

netLibrary - eBook Summary Structure-based Drug Design by ...

netLibrary - eBook Summary Structure-based Drug Design by ...

netLibrary - eBook Summary Structure-based Drug Design by ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Document<br />

Page 323<br />

been suggested that specificity of proteinases in general is due to rigidity in the binding pockets [6];<br />

broad specificity results from the ability of the pockets to change shape in response to different ligand<br />

side chains. However, renin is known to be inhibited <strong>by</strong> a wide variety of peptide analogs of different<br />

length and sequence indicating either that the active site may be somewhat flexible or that the strength<br />

of binding of a substrate does not determine the rate of subsequent turnover. This is emphasised <strong>by</strong> the<br />

existence of substrates that act as competitive inhibitors, e.g., RIP of Haber and Burton [7], which has a<br />

K i that is lower than the K m. Therefore hydrolysis of bound substrate appears to be more specific than<br />

the binding step. This may be because only certain substrate sequences allow correct positioning of the<br />

scissile bond for hydrolysis. Evidence for this effect was provided <strong>by</strong> comparison of 21 inhibitor<br />

structures of endothiapepsin [8], where it was shown that for inhibitors with different sequences but with<br />

the same transition state analog, the scissile bond analog can be disposed somewhat differently with<br />

respect to the catalytic carboxyls in each case.<br />

The availability of crystal structures of a number of renin inhibitors complexed with fungal aspartic<br />

proteinases [8, 9] allowed new compounds to be designed and modeled <strong>by</strong> such techniques as computer<br />

graphics, energy minimization, and molecular dynamics [10]. X-ray crystallographic analysis of aspartic<br />

proteinase inhibitor complexes has made a significant contribution to rationalizing the activity data for<br />

many of these compounds as well as understanding the catalytic mechanism of this class of proteinase.<br />

II. Strategies for <strong>Design</strong> of Renin Inhibitors<br />

Some of the parameters that have been varied in the search for therapeutically active renin inhibitors are<br />

outlined below.<br />

A. Elaboration of the Transition State Analog<br />

There is no evidence that aspartic proteinase catalysis involves a covalently bound intermediate [11] and<br />

major advances in the design of nonhydrolysable analogs have stemmed from attempts to mimic an<br />

intermediate of the following form.<br />

http://legacy.netlibrary.com/nlreader/nlReader.dll?bookid=12640&filename=Page_323.html [4/5/2004 5:24:33 PM]

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!